Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
2025 Global: Bevacizumab Biosimilar Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
2025 Global: Biologics And Biosimilars Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
U.S. Pharmaceutical Third-party Logistics Services Market Size, Share & Trends Analysis Report By Product Type (Branded, Cell Therapy, Biosimilar), By Temperature (Ambient, Refrigerated), By Therapeutic Area, By Manufacturer Size, By Service, And Segment Forecasts, 2025 - 2030
... of 8.90% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven due to the growing demand for efficient and secure supply chain solutions, increasing complexity in ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
U.S. Pharmaceutical Packaging Services Market Size, Share & Trends Analysis Report By Product (Branded, Generic, Biosimilar, Vaccine, Cell Therapy, Gene Therapy), By Service Line, By Manufacturer Size, And Segment Forecasts, 2025 - 2030
... 2025 to 2030, according to a new report by Grand View Research, Inc. The U.S. pharmaceutical industry is heavily regulated by agencies such as the Food and Drug Administration (FDA), which mandates strict packaging guidelines ... Read More
-
Global High Potency APIs Market Size study, by Type (Innovative, Generic), by Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), by Manufacturers (Captive, Merchant), by Application (Oncology, Hormonal Imbalance, Glaucoma) and Regional Forecasts 2022-2032
... global High Potency APIs (HPAPIs) market is currently valued at approximately USD 26.97 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 10.10% during the forecast period from ... Read More
-
2025 Global Forecast for Biosimilar Contract Manufacturing Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
Psoriasis Biosimilars Market Forecasts to 2030 – Global Analysis By Product (Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Rituximab Biosimilars, Etanercept Biosimilars and Other Products), Therapy Type, Application, End User and By Geography
... Stratistics MRC, the Global Psoriasis Biosimilars Market is accounted for $10.27 billion in 2024 and is expected to reach $25.31 billion by 2030 growing at a CAGR of 12.2% during the forecast period. Psoriasis biosimilars ... Read More
-
Global Avastin (Bevacizumab) Biosimilars Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Avastin (Bevacizumab) is a medication used to treat a number of types of ... Read More
-
Global Avastin (Bevacizumab) Biosimilars Market Growth 2024-2030
... the Avastin (Bevacizumab) Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Avastin (Bevacizumab) ... Read More
-
Global G-CSF Biosimilars Market Growth 2024-2030
... Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global G-CSF Biosimilars market. G-CSF Biosimilars ... Read More
-
Global HGH Biosimilars Market Growth 2024-2030
... Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global HGH Biosimilars market. HGH Biosimilars ... Read More
-
Global Insulin Biosimilars Market Growth 2024-2030
... Insulin Biosimilars is forecast to a readjusted size of US$ 1858.4 million by 2030 with a CAGR of 3.6% during review period. The research report highlights the growth potential of the global Insulin Biosimilars market. ... Read More
-
Biosimilars Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034
... CAGR to reach market size worth USD 117.1 billion by 2034. The biosimilars market is experiencing a period of rapid growth and evolution, driven by the increasing demand for affordable alternatives to expensive biologic drugs. ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Monoclonal antibodies (mAbs) Biosimilars is forecast to a readjusted size of US$ 5256.8 million by 2030 with a CAGR of 2.0% during review period. The research report highlights ... Read More
-
Global Biosimilars Insulin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Biosimilars is a biological product designed to have similar active properties to the one that ... Read More
-
Rare Disease Treatment Market Assessment, By Drug Type [Biologics, Biosimilars, Small Molecules], By Patient [Adult, Pediatric, Geriatric], By Therapeutic Area [Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, Infectious Diseases, Others], Mode of Administration [Oral, Injectable, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F Global hemophilia market is projected to witness a CAGR of 5.50% during the forecast period 2024-2031, growing from USD ... Read More
-
Global Biosimilars and Biologics Market - 2024-2031
... the forecast period 2024- 2031. Biologics are a category of medical products derived from or containing components of living organisms. Unlike traditional pharmaceuticals, typically made through chemical synthesis, biologics are produced using biotechnology, involving complex ... Read More
-
Global Tocilizumab Biosimilars Market Growth 2024-2030
... thereby modulating the inflammatory response. The global Tocilizumab Biosimilars market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from ... Read More
-
Global Ustekinumab Biosimilars Market Growth 2024-2030
... Biosimilars market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030. LP Information, Inc. (LPI) ' ... Read More
-
2024 Germany Bio-Pharma Logistics Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
Bioprocess Analyzers Market
... tools used to monitor and optimize bioprocesses, which involve the use of living cells or their components to produce products such as biopharmaceuticals, biofuels, and other biotechnology-driven goods. These analyzers help improve the quality, efficiency, ... Read More
-
Global Biosimilars Market (2nd Edition)
... has experienced significant growth, owing to its improved effectiveness in managing chronic diseases. However, the high costs associated with biologics pose considerable economic and healthcare challenges. As the demand for biologics continues to increase, developers ... Read More
-
Biosimilars Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 2022, and the market is now projected to grow from USD 23.96 billion in 2023 to USD 73.03 billion by 2030, exhibiting a CAGR of 17.3% during the forecast period of 2023-2030. There were concerns ... Read More
-
NFC Market by Offering (NFC ICs, NFC Antennas, NFC Tags, NFC Readers), Operating Mode (Reader Emulation, Peer-to-Peer, Card Emulation), Use Cases (Payment and Transactions, Product Identification, Ticketing, Access Control) - Global Forecast to 2029
... global NFC market was valued at USD 21.69 billion in 2024 and is projected to reach USD 30.55 billion by 2029; it is expected to register a CAGR of 7.1% during the forecast period. NFC ... Read More
Research Assistance
